2m 2m 2m 2m 2m 2m 2m
NUVECTIS PHARMA (NVCT)
NASDAQ
$17.88+$0.32 (+1.85%)
Price as of Jun 23, 2026 7:56 PM EDT- $438.5MMarket Cap
- 119.92%1-Year Change
- BiotechnologyIndustry
NUVECTIS PHARMA (NVCT)
$17.88+$0.32 (+1.85%)
NVCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.55 | ||
Change | +$1.02 (+6.17%) | ||
Open | $16.03 | ||
High | $18.24 | ||
Low | $15.88 | ||
Previous Close | $16.53 | ||
Volume | 281,281 | ||
30-Day Average Volume | 125,742 | ||
1-Week Change | 46.98% | ||
1-Month Change | 69.57% | ||
1-Year Change | 119.92% | ||
3-Year Change | 3.54% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 26.5M | ||
Total Assets | $25.4M | ||
Market Cap | $438.5M | ||
Enterprise Value | $413.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$6.0M | ||
Free Cash Flow | -$6.5M | ||
EBIT | -$6.0M | ||
EBITDA | -$6.0M | ||
Net Working Capital | $14.2M | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -68 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 31 | ||
P/E | -64 | ||
PEG | -4 | ||
Price/Free Cash Flow | -67 | ||
Price/Operating Cash Flow | -67 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue